Form 4: PROCEPT BioRobotics Executive Sells Shares for Tax

EVP and CLO Alaleh Nouri sold 285 shares of PROCEPT BioRobotics to cover tax obligations related to RSU vesting.

Summary

• Alaleh Nouri, EVP, CLO, and Corporate Secretary of PROCEPT BioRobotics, sold 285 shares of common stock.
• The transaction occurred on June 8, 2026, at a price of $28.479 per share.
• The sale was executed to satisfy tax withholding obligations resulting from the vesting of Restricted Stock Units (RSUs) on June 5, 2026.
• Following this transaction, the reporting person retains ownership of 105,069 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely administrative to satisfy tax obligations and does not reflect a change in management sentiment.

Positives

• The transaction was a mandatory sell-to-cover event for tax purposes rather than a discretionary market sale, indicating continued alignment with company equity.

Negatives

• Reduction in direct share ownership by a key executive.

Risks

• None identified; this is a routine administrative transaction.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions are standard practice for executives in the medical technology sector to manage tax liabilities associated with equity compensation plans.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for executive compensation and tax compliance in the U.S. biotech industry.

Stakeholder Impact

• Minimal impact on shareholders as the sale was a routine tax-related transaction.

Next Steps

• None specified.

Key Dates

Keywords

PROCEPT BioRobotics, PRCT, Insider Trading, Form 4, Equity Vesting, Tax Withholding